Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20152016201720182019
Sales11,84,431,582,981,28
EBITDA-42,9-72,4-117-130-143
Operating profit (EBIT)-43,6-73,9-121-130-144
Pre-Tax Profit (EBT)-56,3-83,2-124-131-148
Net income-39,4-48,9-89,8-93,5-113
P/E ratio-11,4-6,93-5,85-5,78-4,98
EPS ( $ )-0,21-0,21-0,40-0,41-0,47
Dividend per Share ( $ )-----
Yield-----
Reference price ( $ )2.4021.4552.339942.339942.33994
Announcement Date04/07/2016
09:05am
04/06/2017
06:33am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20152016201720182019
Debt-----
Finance31027523,995,565,2
Operating income (EBITDA)-42,9-72,4-117-130-143
Leverage
(Debt/EBITDA)
-----
Capital Expenditure3,463,683,003,754,40
Book Value Per Share (BVPS)-0,76 $16,1 $20,3 $-28,3 $
Cash Flow per Share-0,15 $---0,55 $-
Announcement Date04/07/2016
09:05am
04/06/2017
06:33am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 552 M$ -
Entreprise Value (EV) 528 M$ 456 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS)
Capitalization / Revenue 350x 185x
EV / Revenue 335x 153x
EV / EBITDA -4,51x -3,52x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 0,15x 0,12x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) -7 687% -4 381%
operating Leverage (Delta EBIT / Delta Sales) -0,99x -
Net Margin (Net Profit / Revenue) -5 699% -3 143%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   190% 126%
Cash Flow / Sales - -4 389%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,20x 0,74x
EPS & Dividend